2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Polymyositis: new trials by email Literature Review of Polymyositis trials Research Report on Polymyositis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis Itolizumab - Dermatomyositis, Adult Type | Phase 1 | Unknown | Biotech Pharmaceutical Co., Ltd. | 44 | 2023-12-30 | 2023-08-14 |
| Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome | Phase 1 | Unknown | Chongqing Precision Biotech Co., Ltd | 24 | 2023-08-31 | 2023-09-28 |
Dermatomyositis (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Lupus Erythematosus, Systemic (1) · Scleroderma, Systemic (1) · Sjogren's Syndrome (1)
Connective Tissue Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Myositis (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1)
itolizumab (1)
Biotech Pharmaceutical Co., Ltd. (1) · Chongqing Precision Biotech Co., Ltd (1)
China (1)
Liyun Zhang, M.D (1) · Rui Chen (1) · Xiaofeng Zeng (1)